Cargando…

Use of the anti HER-2/neu antibody Herceptin in the treatment of human breast cancer: biological rationale and clinical results

Detalles Bibliográficos
Autor principal: Slamon, DJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2000
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300833/
http://dx.doi.org/10.1186/bcr134
_version_ 1782226369290174464
author Slamon, DJ
author_facet Slamon, DJ
author_sort Slamon, DJ
collection PubMed
description
format Online
Article
Text
id pubmed-3300833
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33008332012-03-14 Use of the anti HER-2/neu antibody Herceptin in the treatment of human breast cancer: biological rationale and clinical results Slamon, DJ Breast Cancer Res Oral Presentation BioMed Central 2000 2000-03-12 /pmc/articles/PMC3300833/ http://dx.doi.org/10.1186/bcr134 Text en Copyright ©2000 Current Science Ltd
spellingShingle Oral Presentation
Slamon, DJ
Use of the anti HER-2/neu antibody Herceptin in the treatment of human breast cancer: biological rationale and clinical results
title Use of the anti HER-2/neu antibody Herceptin in the treatment of human breast cancer: biological rationale and clinical results
title_full Use of the anti HER-2/neu antibody Herceptin in the treatment of human breast cancer: biological rationale and clinical results
title_fullStr Use of the anti HER-2/neu antibody Herceptin in the treatment of human breast cancer: biological rationale and clinical results
title_full_unstemmed Use of the anti HER-2/neu antibody Herceptin in the treatment of human breast cancer: biological rationale and clinical results
title_short Use of the anti HER-2/neu antibody Herceptin in the treatment of human breast cancer: biological rationale and clinical results
title_sort use of the anti her-2/neu antibody herceptin in the treatment of human breast cancer: biological rationale and clinical results
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300833/
http://dx.doi.org/10.1186/bcr134
work_keys_str_mv AT slamondj useoftheantiher2neuantibodyherceptininthetreatmentofhumanbreastcancerbiologicalrationaleandclinicalresults